Cleared Special

K253854 - MONTAGE XT Cranial Cement (FDA 510(k) Clearance)

Jan 2026
Decision
30d
Days
Class 2
Risk

K253854 is an FDA 510(k) clearance for the MONTAGE XT Cranial Cement. This device is classified as a Methyl Methacrylate For Cranioplasty (Class II - Special Controls, product code GXP).

Submitted by Orthocon, Inc. (Stamford, US). The FDA issued a Cleared decision on January 2, 2026, 30 days after receiving the submission on December 3, 2025.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5300.

Submission Details

510(k) Number K253854 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2025
Decision Date January 02, 2026
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXP — Methyl Methacrylate For Cranioplasty
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5300